Bio Pharma Dive
MARCH 23, 2022
The deal, announced alongside a $175 million round, makes biotech entrepreneur Greg Verdine's startup the most well-funded among an emerging group of companies searching for drugs in fungal DNA.
World of DTC Marketing
MARCH 23, 2022
Accelerated Approval allows for early access to drugs and biologics based on initial evidence of safety and effectiveness, while confirmatory studies required to verify clinical benefits are ongoing. Do patients care? No. Accelerated Approval was developed in 1992 in response to the HIV/AIDS crisis and has led to expedited drug and biologic approvals in several disease areas across the FDA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 23, 2022
Etrasimod, the basis of the $7 billion acquisition and a potential rival to Bristol Myers Squibb's Zeposia, has cleared the first of two trials in ulcerative colitis.
Deltaclinical
MARCH 23, 2022
Don’t miss us at the Annual Conference by Healixia on March 24th! A great opportunity to network with likeminded in the field of patient centric solutions for healthcare. ???? ???? Our managing director Geert Briers will be hosting a break-out session about Home Therapy. ???? Afterward Geert will be able to answer any additional questions regarding his vast experience in the field of clinical home studies.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
MARCH 23, 2022
Study results showed two shots of Moderna's vaccine led to similar immune responses as has been observed in young adults, although protection versus omicron was modest.
Deltaclinical
MARCH 23, 2022
Don’t miss us at the Annual Conference by Healixia on March 24th! A great opportunity to network with likeminded in the field of patient centric solutions for healthcare. ?. ? Our managing director Geert Briers will be hosting a break-out session about Home Therapy. ? Afterward Geert will be able to answer any additional questions regarding his vast experience in the field of clinical home studies.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Deltaclinical
MARCH 23, 2022
Don’t miss us at the Annual Conference by Healixia on March 24th! A great opportunity to network with likeminded in the field of patient centric solutions for healthcare. Our managing director Geert Briers will be hosting a break-out session about Home Therapy. Afterward Geert will be able to answer any additional questions regarding his vast experience in the field of clinical home studies.
pharmaphorum
MARCH 23, 2022
Four out of five biopharma companies think that the market opportunity for connected health products exceeds their traditional drug business, but adoption remains low, with only 20% of use cases at present going beyond proof of concept. That’s one of the conclusions of a new study by Capgemini, which suggests that the number of approved connected health offerings – digital health products and services including wearables, digital therapeutics and software-as-a-medical-device (SaMD) – will
NY Times
MARCH 23, 2022
The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic Covid-19.
pharmaphorum
MARCH 23, 2022
Whether you’re a large pharma company or a small, emerging one, communication is key. Success or failure hinges on communicating the advantages of your offerings to both prescribing providers and patients. Join us on Tuesday 12 th April at 13:00 BST / 14:00 CET / 8:00 am EDT as panelists lay out how a better approach to communication can lead to improved patient outcomes, preventing drop-off rates, better predicting product forecasts, increasing script volume, integrating localised digital strat
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
MARCH 23, 2022
Lugano, Switzerland, 23 March 2022 – A consensus reached by a lung clinical community within the International Cancer Benchmarking Partnership (ICBP), (1) presented at the European Lung Cancer Congress (ELCC), 30 March – 2 April 2022, has highlighted international disparities in management and outcomes of patients with lung cancer in high-income countries, and has provided a […].
pharmaphorum
MARCH 23, 2022
It’s only been two weeks since Pfizer closed its $6.7 billion takeover of Arena Pharmaceuticals, and it already has the positive data it was hoping for with etrasimod, the main asset in the deal. In its first phase 3 readout, oral S1P receptor modulator etrasimod met its objectives in patients with moderately-to-severely active ulcerative colitis, who had previously failed or were intolerant to at least one prior conventional, biological or JAK inhibitor therapy.
Scienmag
MARCH 23, 2022
East Hanover, NJ, March 23, 2022. Kessler Foundation researchers published results of a survey of the emotional outcomes of individuals with multiple sclerosis (MS) during the COVID-19 pandemic. Comparison of data collected during the pandemic with pre-pandemic data for the study sample suggests the occurrence of pandemic-specific depression and anxiety.
pharmaphorum
MARCH 23, 2022
Merck & Co’s chief medical officer and head of clinical development Dr Roy Baynes has announced his retirement from the company to take up a new role alongside his former colleague Roger Perlmutter at biotech Eikon Therapeutics. Baynes will bring a nine-year stint at Merck, known as MSD outside North America, to an end in July, when he will be replaced by Dr Eliav Barr, currently senior vice president of global clinical development.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
MARCH 23, 2022
Focal cortical dysplasia is a malformation of the cerebral cortex associated with one of the most severe types of epilepsy. Treatment is difficult owing to a lack of effective drugs or access to surgery. A new human model developed by researchers at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, using […].
Pharma Times
MARCH 23, 2022
Digital-first patient care is a priority as the companies join forces to improve patients' lives
Scienmag
MARCH 23, 2022
New Edith Cowan University (ECU) research has revealed Western Australian women with a breech presenting baby may feel pressure to have a caesarean section, without being informed of all options available to them. Credit: Unsplash New Edith Cowan University (ECU) research has revealed Western Australian women with a breech presenting baby may feel pressure to […].
Pharma Times
MARCH 23, 2022
Groups including those aged over 75-years-old, care home residents and the immunocompromised will be entitled to a fourth jab
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MARCH 23, 2022
Combining Black Racial Groups Hides Health Disparities in Breastfeeding A new study from Amira Roess in the Department of Global and Community Health highlights the differences in breastfeeding initiation between African Americans and Black immigrants enrolled in the Washington, D.C. WIC supplemental nutrition program. Illnesses such as sudden infant death syndrome, asthma, and obesity disproportionally […].
pharmaphorum
MARCH 23, 2022
With initiatives like The 100,000 Genome Project, the UK has led the world on genomic research. In a bid to maintain that position, the governments of all four UK nations have now pledged their support for the sectors’ industry players. Representatives from industry associations and the governments and NHS in all four UK nations will meet to discuss the future of the country’s genomics sector.
Scienmag
MARCH 23, 2022
Demand response, a measure taken to reduce the energy load in response to supply constraints, within the Texas electric grid has been a topic of recent conversation after the wake of Winter Storm Uri just one year ago. Demand response can enhance the reliability of the grid through renewable energy penetration and also significantly reduce […].
pharmaphorum
MARCH 23, 2022
In this webinar, speakers from the NIHR and Roche will discuss what data is available to life science companies and CROs, how it’s currently being used for research planning and placement, and what more could be done with that data. They’ll also look at what culture and process changes will be required to make sure this data can be readily translated into insights to improve commercial research delivery.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MARCH 23, 2022
URBANA, Ill. – Scientists at the University of Illinois at Urbana-Champaign and Mie University in Japan have developed monoclonal antibodies that prevent lung cell death in mouse models for idiopathic pulmonary fibrosis (IPF) and acute respiratory disease syndrome (ARDS). The advance, along with new, non-invasive diagnostic tools presented in the same study, could be a […].
The Pharma Data
MARCH 23, 2022
Roche today announced the donation of additional medicines and diagnostics to Ukraine. Beyond the already communicated 150,000 packs of an antibiotic medicine the new donation includes another 4,600 packs of specialized medicines for the treatment of influenza, rheumatoid arthritis, SMA and various cancers. We are also donating reagents and consumables for automatic testing of up to 120,000 blood donations and 31,000 units for diabetes management.
Scienmag
MARCH 23, 2022
Bethesda, MD (March 23, 2022) – The American Gastroenterological Association (AGA) has selected 18 distinguished early career gastroenterologists and hepatologists for its 2022-2023 class of AGA Future Leaders. The 18-month program cultivates effective leadership skills for professional advancement in AGA and within the field of digestive diseases. Credit: American Gastroenterological Association Bethesda, MD (March 23, […].
The Pharma Data
MARCH 23, 2022
The only large-scale prospective study in dermatology designed to generate key disease insights among Black, Hispanic, Asian, Indigenous and other people of color Study reinforces Janssen’s commitments to inclusive clinical research and addressing health inequities. Psoriasis (PsO) can take a physical, psychological, and emotional toll on the more than 8 million Americans living with the disease; and for people of color, there are additional challenges due to limited medical research and educati
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MARCH 23, 2022
A new study has found that costs of conservation projects are rarely reported, making it difficult for others to make decisions on the most cost-effective interventions at a time when funding for biodiversity conservation is severely limited. A review of 1,987 published reports of conservation interventions has found that only 8.8% reported the total cost […].
The Pharma Data
MARCH 23, 2022
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Dr. Roy D. Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. Dr. Baynes will be succeeded by Dr. Eliav Barr, effective April 1, 2022. Dr. Baynes will continue to report to Dr.
Scienmag
MARCH 23, 2022
[Points] Credit: National Institute of Information and Communications Technology (NICT) & Financial Services Agency of Japan (JFSA) [Points] ?The NICT and the JFSA have developed a new high-precision AI-based translation engine that can translate documents in the financial sector between Japanese and English. ?The JFSA has collected a large quantity of bilingual documents from a […].
The Pharma Data
MARCH 23, 2022
– ELEVATE 12 study met primary and key secondary endpoints of improving clinical remission at week 12 – – Safety profile consistent with previous Phase 2 studies – Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) receptor modulator in development for the treatment of moderately to severely active ulcerative colitis (UC).
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
317 
Let's personalize your content